NORMAL SITUATION

APOTHEEK VAN WEMMEL

Export PDF

Company — Normal situation.

Financial year 2021 · Closed on 31/12/2021

Net result39,1 k €-83,7 %over 1 year

Gross margin302,1 k €-46,7 %over 1 year

Equity205,7 k €+23,5 %over 1 year

Workforce2,7 ETP-27,0 %over 1 year

Identity

Source · BCE/KBO

APOTHEEK VAN WEMMEL is a company registered in Belgium. It employs on average 2,7 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0432.763.322
Legal form: Public limited company
Contributed capital: 61 974,00 €
Latest accounts: 31/12/2021
Average workforce: 2,7 ETP

Joint committees (2)

Signals

ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 34 filings

Trend over 16 financial years

	2021		2020		2019		2018		2017
Income statement
Gross margin	302,1 k €	-46.7%	567,1 k €	+48.4%	382,1 k €	+3.3%	369,8 k €	-8.4%	403,5 k €
EBITDA	149,1 k €	-54.6%	328,3 k €	+80.8%	181,6 k €	-11.9%	206,1 k €	-18.8%	253,9 k €
Operating result	82,1 k €	-68.2%	258,2 k €	+133%	111 k €	-16.5%	132,9 k €	-24.7%	176,6 k €
Net result	39,1 k €	-83.7%	240,2 k €	+185%	84,2 k €	-22.7%	109 k €	-27.0%	149,2 k €
Balance sheet
Equity	205,7 k €	+23.5%	166,7 k €	+0.1%	166,5 k €	+0.8%	165,2 k €	+9.2%	151,3 k €
Total assets	574,1 k €	-36.6%	906 k €	+5.3%	860,7 k €	-8.5%	940,8 k €	-1.1%	951,2 k €
Cash	168,9 k €	+594%	24,3 k €	+207%	7,9 k €	-68.3%	25 k €	-68.5%	79,4 k €
Debts	368,4 k €	-49.9%	734,7 k €	+6.2%	691,5 k €	-10.4%	771,6 k €	-3.1%	795,9 k €
Other
Workforce	2,7 ETP	-27.0%	3,7 ETP	+5.7%	3,5 ETP	-18.6%	4,3 ETP	+38.7%	3,1 ETP

Board of directors

Source · NBB, accounts to 31/12/2021

4 active · 22 ended

Active mandates

Alain Bogaert

Director · since 04 octobre 2021 · until 13 juin 2024

Active

Cindy Dewitte

Director · since 04 octobre 2021 · until 13 juin 2024

Active

Geert Reniers

Director · since 04 octobre 2021 · until 13 juin 2024

Active

Marie Christine Camerlinck

Director · since 28 février 2019 · until 04 octobre 2022

Active

Ended mandates

Marie Christine Camerlynck

Director · since 28 février 2019

Ended

Geraldine Janssens

Director · since 21 octobre 2016 · until 21 octobre 2022

Ended

PV Invest Pharma

Managing director · since 21 octobre 2016 · until 21 octobre 2022 · 0893.658.030

Represented by Pieter Vermeersch

Ended

Christine Camerlynck

Director · since 14 juin 2013 · until 21 octobre 2016

Ended

Full financial information

Source · NBB

	2021	2020	2019	2018	2017	2016
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2021	01/01/2020	01/01/2019	01/01/2018	01/01/2017	01/01/2016
Closing of the financial year	31/12/2021	31/12/2020	31/12/2019	31/12/2018	31/12/2017	31/12/2016
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	22/06/2022	13/07/2021	10/07/2020	11/07/2019	12/06/2018	14/07/2017
General meeting	09/06/2022	30/06/2021	12/06/2020	14/06/2019	08/06/2018	30/06/2017
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 34 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2021	09/06/2022	22/06/2022	French	PDF
Abridged model	31/12/2020	30/06/2021	13/07/2021	Dutch	PDF
Abridged model	31/12/2019	12/06/2020	10/07/2020	Dutch	PDF
Abridged model	31/12/2018	14/06/2019	11/07/2019	Dutch	PDF
Abridged model	31/12/2017	08/06/2018	12/06/2018	Dutch	PDF
Abridged model	31/12/2016	30/06/2017	14/07/2017	Dutch	PDF
Abridged model	31/12/2015	10/06/2016	14/06/2016	Dutch	PDF
Abridged model	31/12/2014	12/06/2015	17/07/2015	Dutch	PDF
Abridged model	31/12/2013	13/06/2014	17/06/2014	Dutch	PDF
Abridged model	31/12/2012	14/06/2013	25/07/2013	Dutch	PDF
Abridged model	31/12/2011	08/06/2012	22/08/2012	Dutch	PDF
Abridged model	31/12/2010	10/06/2011	27/07/2011	Dutch	PDF
Abridged model	31/12/2009	11/06/2010	26/08/2010	Dutch	PDF
Abridged model	31/12/2008	12/06/2009	30/07/2009	Dutch	PDF
Abridged model	31/12/2007	24/10/2008	02/12/2008	Dutch	PDF
Abridged model	31/12/2006	01/06/2007	07/06/2007	Dutch	PDF
Abridged model	31/12/2005	02/06/2006	28/06/2006	Dutch	PDF
Abridged model	31/12/2004	03/06/2005	26/07/2005	Dutch	PDF
Abridged model	31/12/2003	04/06/2004	29/06/2004	Dutch	PDF
Abridged model	31/12/2002	06/06/2003	27/06/2003	Dutch	PDF
Abridged model	31/12/2001	07/06/2002	24/06/2002	Dutch	PDF
Abridged model	31/12/2000	01/06/2001	27/06/2001	Dutch	PDF
Abridged model	31/12/1999	02/06/2000	21/06/2000	Dutch	PDF
Abridged model	31/12/1998	11/06/1999	23/06/1999	Dutch	PDF

View all 34 filings

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2021

4 active · 22 ended

Active mandates

Alain Bogaert

Director · since 04 octobre 2021 · until 13 juin 2024

Active

Cindy Dewitte

Director · since 04 octobre 2021 · until 13 juin 2024

Active

Geert Reniers

Director · since 04 octobre 2021 · until 13 juin 2024

Active

Marie Christine Camerlinck

Director · since 28 février 2019 · until 04 octobre 2022

Active

Ended mandates

Marie Christine Camerlynck

Director · since 28 février 2019

Ended

Geraldine Janssens

Director · since 21 octobre 2016 · until 21 octobre 2022

Ended

PV Invest Pharma

Managing director · since 21 octobre 2016 · until 21 octobre 2022 · 0893.658.030

Represented by Pieter Vermeersch

Ended

Christine Camerlynck

Director · since 14 juin 2013 · until 21 octobre 2016

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette

Dissolution30/06/2022
RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ... - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Restructuring11/04/2022
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Mandates18/10/2021
MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
PDF
Mandates08/03/2019
ONTSLAGEN - BENOEMINGEN
PDF
Mandates24/11/2016
ONTSLAGEN - BENOEMINGEN
PDF
Mandates29/08/2014
ONTSLAGEN - BENOEMINGEN
PDF
Mandates12/09/2013
ONTSLAGEN - BENOEMINGEN
PDF
Registered office13/03/2012
BENAMING - MAATSCHAPPELIJKE ZETEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2021
Annual accounts 202139,1 k €↓
2020
Annual accounts 2020240,2 k €↑
2019
Annual accounts 201984,2 k €↓
2018
Annual accounts 2018109 k €↓
2017
Annual accounts 2017149,2 k €↑
2016
Annual accounts 201687,8 k €↑
2015
Annual accounts 201551,5 k €↑
2014
Annual accounts 201427,9 k €↑
2013
Annual accounts 2013-45,2 k €↑
2012
Annual accounts 2012-84,1 k €↓
2011
Annual accounts 2011-24,9 k €↓
2010
Annual accounts 201010,5 k €↓
2009
Annual accounts 200924,7 k €↑
2008
Annual accounts 2008-15,1 k €↓
2007
Annual accounts 200751,4 k €↓
2006
Annual accounts 2006108,7 k €

APOTHEEK VAN WEMMEL

Overview

Identity

Financials

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline